Get the Stockscreener App
3.26
3.85%
-0.12
Ac Immune Sa stock is traded at $3.26, with a volume of 159.54K.
It is down -3.85% in the last 24 hours and down -18.55% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$3.38
Open:
$3.35
24h Volume:
159.54K
Relative Volume:
0.64
Market Cap:
$326.33M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-4.5948
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
-9.47%
1M Performance:
-18.55%
6M Performance:
+88.95%
1Y Performance:
+8.33%
1-Day Range:
$3.11
$3.35
1-Week Range:
$3.11
$4.00
52-Week Range:
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
3.25 | 340.03M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Will AC Immune SA (IMR) stock extend growth story2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
How to interpret RSI for AC Immune SA stockJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Why AC Immune SA stock remains on watchlistsQuarterly Growth Report & Fast Gain Swing Alerts - newser.com
Key resistance and support levels for AC Immune SA2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Can AC Immune SA stock sustain free cash flow growthTrade Entry Summary & Long-Term Safe Return Strategies - newser.com
Why analysts remain bullish on AC Immune SA stockQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
Signal strength of AC Immune SA stock in tech scannersJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
Can AC Immune SA stock continue upward trendJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Will a bounce in AC Immune SA offer an exitTrade Risk Assessment & Growth Oriented Trading Recommendations - newser.com
Can swing trading help recover from AC Immune SA losses2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Detecting support and resistance levels for AC Immune SA2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
How resilient is AC Immune SA stock in market downturnsJuly 2025 Movers & Safe Capital Investment Plans - newser.com
Pattern recognition hints at AC Immune SA upsidePrice Action & Precise Entry and Exit Recommendations - newser.com
What MACD and RSI say about AC Immune SAJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Real time pattern detection on AC Immune SA stockJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
Is AC Immune SA (IMR) stock resilient in recession scenarios2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Applying Wyckoff theory to AC Immune SA stockIPO Watch & Stepwise Entry and Exit Trade Signals - newser.com
AC Immune SA (ACIU) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
AC Immune And 2 Other Promising Penny Stocks - Yahoo Finance
Will AC Immune SA stock recover after recent dropTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
How to escape a deep drawdown in AC Immune SABear Alert & Community Trade Idea Sharing - newser.com
Can AC Immune SA stock resist sector downturns2025 Dividend Review & Verified Entry Point Signals - newser.com
AC Immune announces publication of preclinical data on ACI-19626 - MSN
AC Immune SA Hits New 52-Week High of $4.00, Marking Major Milestone - Markets Mojo
AC Immune appoints Mummery as Chair of Clinical Advisory Board - MSN
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):